Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse CXCL11 ELISA Kit (AC3034)
Cat.#: ASET-1623
Specifications
Description Mouse CXCL11 ELISA Kit allows for the in vitro quantitative determination of mouse CXCL11 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 37.5 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 62.5-4000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1657 Rat Thyroid Hormone Receptor alpha ELISA Kit (AC3068) Quantitative inquiry ASET-1081 Human Galectin 7 ELISA Kit (AC2492) Quantitative inquiry ASET-2110 Human CNPase ELISA Kit (AC3521) Quantitative inquiry ASET-1630 Monkey Prealbumin ELISA Kit (AC3041) Quantitative inquiry ASET-2404 Porcine TSH ELISA Kit (AC3815) Quantitative inquiry ASET-2512 Rat Oxytocin ELISA Kit (AC3923) Quantitative inquiry ASET-1384 Mouse MMP24 ELISA Kit (AC2795) Quantitative inquiry ASET-2531 Rat Tyrosine Hydroxylase ELISA Kit (AC3942) Quantitative inquiry ASET-1239 Mouse AGRP ELISA Kit (AC2650) Quantitative inquiry ASET-2399 Human PITPNC1 ELISA Kit (AC3810) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket